好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Stroke Simulation with Deliberate Practice Method Significantly Increases Knowledge and Confidence Among Incoming Neurology Residents
好色先生, Research, and Methodology
P5 - Poster Session 5 (8:00 AM-9:00 AM)
5-026

Our objective was to investigate the effect of a stroke simulation on knowledge and confidence in managing stroke alerts among first-year neurology residents.
For incoming neurology residents, stroke alerts can be a daunting new practice of timely recognition of acute symptoms they have not witnessed in the real world yet. Nevertheless, optimal diagnosis and treatment of stroke requires knowledge of options available for hyperacute intervention and effective communication with patients and other healthcare workers in an expedited manner.  Medical simulation programs have shown promising results utilizing the “deliberate practice method” (DPM), which allows a focused “safe space” to allow errors and learn from them through repetition. A longitudinal evaluation of neurology residents’ participation in stroke training with DPM, simultaneously comparing pre- and post-simulation knowledge and confidence assessments, has not yet been reported.
For 10 years (2015-2024), we investigated the effect of DPM with stroke simulations on knowledge and confidence in managing a stroke alert among first-year neurology residents. The simulation included a robot mannequin and standardized patient actors with various case scenarios that mimicked stroke syndromes. After each scenario, a vascular neurologist debriefed each case with participants, who were given pre- and post-tests on knowledge and confidence of stroke management, including thrombolytic shared decision-making.
Ninety first-year neurology residents underwent a “Stroke Patient Simulation” course, which was offered every year for a decade. Residents’ knowledge significantly improved from 8.07/10 (pre-test mean, SD 1.96) to 9.78/10 (post-test mean, SD 1.47), p<0.05 (overall effect size 0.98). Confidence significantly improved from 2.84/5 (pre-test mean SD 1.01) to 3.92/5 (post-test mean, SD 0.74), p<0.05 (overall effect size 1.17).
DPM optimizes residents’ stroke management strategies before practicing upon real-world patients in the hyperacute setting by significantly improving knowledge and confidence with annual stroke simulation programs.
Authors/Disclosures
Alena Makarova, MD
PRESENTER 		Dr. Makarova has nothing to disclose.
Michael Brannick, PhD Prof. Brannick has nothing to disclose.
Charles D. Schutt, MD (USF Neurology) Dr. Schutt has nothing to disclose.
Shreyas Gangadhara, MD, FAAN (University of Mississippi Medical Center) Dr. Gangadhara has nothing to disclose.
Swetha Renati, MD (University of South Florida) Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a NeuroSAE with 好色先生 .
Kanita Beba Abadal, MD (University of South Florida College of Medicine) Dr. Beba has nothing to disclose.
Andrea Bozeman, NP (USF) Mrs. Bozeman has nothing to disclose.
Karen P. Wilson, RN Ms. WILSON has nothing to disclose.
Clifton L. Gooch, MD, FAAN (University of South Florida) Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Britany Mills, PhD Dr. Mills has nothing to disclose.
William S. Burgin, MD Dr. Burgin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for VuEssence. Dr. Burgin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Burgin has stock in VuEssence. The institution of Dr. Burgin has received research support from VuEssence. The institution of Dr. Burgin has received research support from Bristol-Myers Squibb. The institution of Dr. Burgin has received research support from ReNeuron.
David Z. Rose, MD (USF) Dr. Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Chiesi USA. Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL-Behring .